A detailed history of Landscape Capital Management, L.L.C. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Landscape Capital Management, L.L.C. holds 52,012 shares of GILD stock, worth $4.89 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
52,012
Previous 53,989 3.66%
Holding current value
$4.89 Million
Previous $3.7 Million 17.68%
% of portfolio
0.49%
Previous 0.34%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$66.59 - $83.99 $131,648 - $166,048
-1,977 Reduced 3.66%
52,012 $4.36 Million
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $3.09 Million - $3.57 Million
48,982 Added 978.27%
53,989 $3.7 Million
Q1 2024

May 09, 2024

BUY
$71.58 - $87.29 $358,401 - $437,061
5,007 New
5,007 $366,000
Q4 2019

Feb 11, 2020

SELL
$61.62 - $67.78 $895,585 - $985,114
-14,534 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $908,520 - $1 Million
14,534 New
14,534 $921,000
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $476,416 - $533,710
-7,619 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $76,583 - $99,935
1,265 Added 19.91%
7,619 $477,000
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $820,290 - $908,211
-11,508 Reduced 64.43%
6,354 $491,000
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $344,447 - $401,785
-5,309 Reduced 22.91%
17,862 $1.27 Million
Q1 2018

May 11, 2018

BUY
$72.84 - $88.8 $278,030 - $338,949
3,817 Added 19.72%
23,171 $1.75 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $994,605 - $1.17 Million
13,979 Added 260.07%
19,354 $1.39 Million
Q3 2017

Nov 14, 2017

SELL
$72.11 - $85.47 $223,829 - $265,298
-3,104 Reduced 36.61%
5,375 $435,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,479
8,479 $600,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Landscape Capital Management, L.L.C. Portfolio

Follow Landscape Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.